Abstract

Objectives Urinary stem cells (USCs) have the capacity for unlimited growth and are promising tools for the investigations of cell differentiation and urinary regeneration. However, the limited life span significantly restricts their usefulness. This study is aimed at exploring the effect of integrin-linked kinase (ILK) on the smooth muscle cells (SMCs) differentiation of the dog USCs and investigating its molecular mechanism. Methods An immortalized USCs cell line with the molecular markers and biological functions was prepared. After successfully inducing the differentiation of USCs into SMCs, the expression level of the unique key factor and its mechanisms in this process was determined through real-time polymerase chain reaction, Western blot, or Immunofluorescence staining. Results We found that high cell density promoted USCs differentiation SMCs, and ILK was necessary for USCs differentiation into SMCs. Knocking down ILK decreased the expression of SMCs specific-marker, while using a selective ILK agonist increased the expression of SMCs specific-marker. Furthermore, ILK regulated SMCs differentiation in part through the activation of NF-κB pathway in USCs. A NF-κB activity assay showed overexpression of ILK could significantly upregulate NF-κB p50 expression, and NF-κB p50 acts as downstream signal molecular of ILK. Conclusion High cell density induces the differentiation of USCs into SMCs, and ILK is a key regulator of myogenesis. Furthermore, NF-κB signaling pathway might play a crucial role in this process.

Highlights

  • Urinary stem cells (USCs) are pluripotent stem cells derived from voided urine [1, 2]

  • We identified an immortalized dog USCs cell line, with the certain molecular markers and biological functions; our data displayed that USCs hold smooth muscle cells (SMCs) differentiation potential, induced in cell-cell adhesion, and this process was mediated through integrin-linked kinase (ILK)

  • Flow cytometry was used to detect marker expression of these cells; we found that USCs were strongly positive for pluripotent stem cell markers SSEA-4, CD29, CD90, and CD24 and weakly positive for CD31, CD133, and CD105

Read more

Summary

Introduction

Urinary stem cells (USCs) are pluripotent stem cells derived from voided urine [1, 2]. It has been proved that USCs have the capacity for unlimited growth, self-renewal, and differentiation toward multiple cell lines including endothelial, osteogenic, adipogenic, and neural lineages [3]. Due to their high differentiation potential, USCs could be an excellent alternative cell source in cellbased therapies for many diseases. Literatures have demonstrated that USCs can differentiate into smooth muscle cells (SMCs) in response to growth factor simulation [4]. How exactly USCs differentiate into SMCs remains unknown, which further limits the possibility of clinical appliance. Understanding the molecular mechanisms of this differentiation assumes a new urgency

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call